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The distribution and patterning of blood vessels is controlled by vascular endothelial growth factor
(VEGF), which is precisely regulated throughout its life cycle. Okabe et al. show that VEGF is titrated
away from the endothelium by adjacent neurons via endocytosis, regulating density and trajectory
of blood vessels.As a central regulator of angiogen-
esis, vascular endothelial growth factor
(VEGF) is widely expressed during devel-
opment, a time of significant vascular
expansion. Despite this broad expression
pattern, VEGF is precisely and intricately
regulated at multiple levels. From alterna-
tive splicing that generates specific VEGF
isoforms to interactions with extracellular
matrix (ECM) that control VEGF mobility,
VEGF bioavailability is fine-tuned at an
extraordinary scale (Mac Gabhann and
Popel, 2008). In this issue, Okabe et al.
(2014) discover another mode of regula-
tion that contributes to this elaborate
program.
In the developing retina, Okabe et al.
observed thatVEGF isdepletedatamicro-
scale level by engulfment and degrada-
tion in neurons neighboring the vascula-
ture, without an apparent signaling role
in these neurons. Highly localized deple-
tion of VEGF precisely titers cytokine
availability to the developing vascula-
ture and ultimately prevents misdirected
angiogenesis into the neural plane. This
level of growth factor regulation has not
been previously described and introduces
a possible signaling-mediated ‘‘depletion
effect’’ on adjacent receptor-expressing
cells.
While the prevalence of growth factor
depletion is yet to be determined, the
significance of this mode of action must
be considered in the broad context of
VEGF bioavailability, which restricts ac-
cess of VEGF to target receptors through
multiple complex mechanisms (Figure 1).
There are at least 14 different isoforms
of VEGF with various biological activities.
At one extreme, splicing of an alternative
exon 8 has been found to be anti-angio-genic, whereas exclusion of exons 6
and 7 frees VEGF from the ECM, and its
diffusion creates a shallow growth factor
gradient. Longer VEGF isoforms bound
to the ECM can be sequestered away,
generating a steep gradient. When in
contact with matrix-bound VEGF, endo-
thelial cells organize unique cell-surface
receptor complexes that convey distinct
signaling kinetics and downstream
cascades (Chen et al., 2010). The ECM-
VEGF interaction can be further modu-
lated by plasmin and matrix metallopro-
teases, which cleave VEGF to promote
the release of active growth factor from
matrix stores (Lee et al., 2005). Finally,
local levels of soluble VEGFR1, the
‘‘decoy receptor,’’ also affect signaling
by VEGF sequestration. Even upon reach-
ing its receptor(s), cellular outcomes
downstream of VEGF differ depending
on the combination of receptors ex-
pressed by the cell and how readily they
are endocytosed (Eichmann and Simons,
2012). Because vasculogenesis occurs in
synchrony with growth and differentiation
of individual organs, one can envision
a dynamic landscape of VEGF produc-
tion, secretion, protease modification,
and now, based on the work of Okabe
et al., localized depletion. Combined, the
outcome is a stereotypical vascular tree
that is coordinated by the heterogeneous
cellular environment, reflecting the needs
of each organ.
Localized depletion of VEGF is likely
to impact sprouting behavior, including
location and frequency of vascular
branches. Sprouting endothelial ‘‘tip’’
cells have a distinct morphology and
cellular features when compared to ‘‘stalk
cells,’’ a difference partially attributed toCell 159the level of VEGF exposure (Gerhardt
et al., 2003). In the developing retina, for
example, VEGF at the front of the vascular
plexus activates VEGFR2 on tip cells and
is endocytosed as a VEGF/VEGFR2 com-
plex at a higher rate compared to stalk
cells (Nakayama et al., 2013). High levels
of VEGF signaling increase the expression
of the Notch receptor Dll4, which acti-
vates Notch1 in adjacent stalk cells.
Notch1 activation in the stalk cells results
in a negative feedback loop reducing
VEGFR2 expression, making stalk cells
less receptive to extracellular VEGF cues
(Hellstro¨m et al., 2007). The work by
Okabe et al. now modifies this model, as
tip cell endocytosis may deplete VEGF
that would otherwise be available to adja-
cent stalk cells, exacerbating predicted
differences in VEGF availability. Alterna-
tively, VEGF gradients could also exist
at a subcellular level, when the efficiency
of receptor endocytosis varies across
the cell surface, thereby creating com-
partments with distinct signaling com-
plexes dependent on receptor and ligand
distribution.
VEGFR2 expressed by nonendothelial
cells, such as cancer cells and he-
matopoietic cells, usually participates in
signaling cascades that alter cellular
behavior. In the central nervous system,
VEGF orchestrates vessel and neuronal
wiring to stimulate neuron differentiation,
migration, and axon outgrowth, contrib-
uting to the formation of a functional
neural network (Carmeliet et al., 2013).
Therefore, it is assumed that VEGFR2
expression in retinal neurons must be
important for cell-autonomous signaling.
Surprisingly, Okabe et al. show that,
although VEGFR2 is phosphorylated,, October 23, 2014 ª2014 Elsevier Inc. 473
Figure 1. Regulation of VEGF Bioavailability
(A) Low oxygen tension activates the transcription factor HIF1 to promote vascular endothelial growth factor (VEGF) transcription. VEGF transcript is subject to
alternative splicing, the products of which vary in their extracellular matrix (ECM)-binding properties. VEGFmRNA can be targeted by miRNAs that affect protein
production.
(B) Secreted VEGF protein is extensively modified by the extracellular environment. Shorter, soluble VEGF isoforms diffuse freely in the extracellular environment,
whereas longer isoforms bind to specific extracellular matrix (ECM) proteins and are trapped to generate a steep VEGF gradient. VEGF can also be sequestered
by soluble ‘‘VEGF trap’’ receptors. ECM-bound VEGF can be cleaved by extracellular proteases, releasing soluble fragments capable of diffusion and signaling,
similar in action to short VEGF isoforms.
(C) When VEGF successfully reaches a receptor-expressing cell, it binds to the receptor and is endocytosed and degraded. Through degradation, an area of
localized VEGF depletion is created and adjacent cells are deprived of VEGF ligand. The biological activity of VEGF can also be modified by the combination of
receptors expressed by the target cell, leading to different signaling cascades with various cellular outcomes.ablation of this gene in retinal neurons
does not grossly affect the neurons’
growth or differentiation. This result in-
troduces an alternative, biologically sig-
nificant function of receptor expression,
which is to chelate ligand from adjacent
cells. Although it is generally presumed
that the major function of a receptor is to
initiate signaling within the cell, we should
now consider that receptors may also
have an important impact on the extracel-
lular microenvironment. As the authors
speculate, VEGFR2 expression on neuro-
retinal cells may help to maintain a hypox-
ic stem cell niche by preventing excessive
vascularization.
Vascular growth appears to employ
a unique regulatory cascade in which
VEGF is produced and then carefully whit-
tled down to pinpoint locations. Textbook
models of paracrine signaling seem to
suggest systemic flooding of ligands
whose actions are entirely controlled by
the level of receptor. However, the high474 Cell 159, October 23, 2014 ª2014 Elsevienergy cost of extensive VEGF regulation
as well as information from overexpres-
sion models in vivo (Miquerol et al.,
2000) suggests that the rate-limiting step
of VEGF signaling is actually the availabil-
ity of the VEGF ligand, rather than recep-
tors. The work presented by Okabe et al.
provides an additional layer to our under-
standing, indicating that growth factor
can also be controlled by heterotypic cells
that ‘‘steal’’ VEGF from their neighboring
endothelial cells. This mechanism adds
to the already bursting toolkit of VEGF
regulation that may be employed, in
unique combinations, to fulfill the vascu-
larization needs of each tissue.REFERENCES
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